Latest news with #ofAssociation
Associated Press
30-06-2025
- Business
- Associated Press
Total number of shares and voting rights in Zealand Pharma as of June 30, 2025
Company announcement – No. 16 / 2025 Total number of shares and voting rights in Zealand Pharma as of June 30, 2025 Copenhagen, Denmark, June 30, 2025 – Zealand Pharma A/S ('the Company' or 'Zealand Pharma') (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announces, in accordance with section 32 of the Danish Capital Markets Act, the total number of shares and voting rights in the Company at the end of a calendar month during which changes to its share capital have occurred. In Company Announcement No. 14 / 2025 dated June 6, 2025, Zealand Pharma announced a share capital increase due to the exercise of employee warrants. Following this announcement, the table below details the total number of shares and voting rights in Zealand Pharma as of June 30, 2025. The Company's Articles of Association are available on the Company's website # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ('Zealand') is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharmaceutical companies as well as commercial partnerships for its marketed products. Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the United States. For more information about Zealand's business and activities, please visit Contact Adam Lange (Investors) Vice President, Investor Relations [email protected] Neshat Ahmadi (Investors) Investor Relations Manager [email protected] Anna Krassowska (Investors and Media) Vice President, Investor Relations & Corporate Communications [email protected]
Economic Times
04-06-2025
- Business
- Economic Times
YES Bank shares in focus after board clears plan to raise Rs 16,000 crore in equity and debt
YES Bank shares will be in focus on Wednesday after the private lender announced late Tuesday that its board has approved a fundraising plan of up to Rs 16,000 crore for FY26—comprising Rs 7,500 crore through equity and Rs 8,500 crore via debt instruments. The capital raise will be executed in multiple tranches, across both domestic and international markets. ADVERTISEMENT In a regulatory filing, YES Bank said the equity component would be raised using various permissible instruments, with total dilution capped at 10%. The board also approved raising debt capital through instruments denominated in Indian or foreign currency, aggregating to Rs 8,500 crore. Also Read: MRF snatches India's highest-priced stock crown back from Elcid Investments As part of its strategic partnership with Japan's Sumitomo Mitsui Banking Corporation (SMBC), YES Bank will amend its Articles of Association to enable SMBC to infuse fresh equity and increase its stake. On May 9, SMBC signed a definitive agreement to acquire a 20% stake in YES Bank for Rs 13,483 crore via a secondary market deal. Under the agreement, SMBC will receive pro-rata pre-emptive rights to participate in future equity issuances to maintain its stake and will be entitled to nominate two non-executive, non-independent directors to YES Bank's board. State Bank of India (SBI), a key shareholder, will retain the right to appoint one nominee director. YES Bank last raised Rs 15,000 crore in July 2020 through a follow-on public offer. In March 2022, it secured Rs 8,887 crore from Carlyle and Advent International via a preferential issue, with both investors acquiring a 9.99% stake each. ADVERTISEMENT As of March 2025, the bank reported a Common Equity Tier 1 (CET1) ratio of 13.5% and an overall capital adequacy ratio of 15.6%.Also Read: Looking for reliable dividends? These 10 stocks stayed consistent through FY22–FY24 ADVERTISEMENT According to Trendlyne, the average target price for YES Bank is Rs 16, indicating a downside of around 21% from current levels. Among the 12 analysts tracking the stock, the consensus rating is 'Sell'.On Tuesday, YES Bank shares closed at Rs 20.85 on the BSE, down 10.4%, while the benchmark Sensex fell 0.78%. The stock has surged 28% in the past three months but is down 11% over the past year. YES Bank's market capitalisation currently stands at Rs 65,387 crore. ADVERTISEMENT Also Read: India's top 10 priciest stocks in 2025: MRF to Elcid, see who tops the list (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
Mint
04-06-2025
- Business
- Mint
Yes Bank share price gains as board approves raising up to ₹16,000 crore
Yes Bank share price gained over a percent in early trade on Wednesday after the private lender's board approved raising of ₹ 16,000 crore through a mix of equity and debt to fund business growth. Yes Bank shares rose as much as 1.87% to ₹ 21.24 apiece on the BSE. The board of directors of Yes Bank approved raising of funds by way of issuance of eligible equity securities through various permissible means, of up to ₹ 7,500 crore, which would not result in an aggregate dilution of more than 10% (including dilution on account of issuance of equity securities in terms of this item and conversion of any convertible debt securities approved by the board), Yes Bank said in a regulatory filing on June 3. The board also approved raising funds by way of issuance of eligible debt securities in Indian or foreign currency up to ₹ 8,500 crore and would not result in an aggregate dilution of more than 10%, the private lender added. Yes Bank's board also approved amendments to its Articles of Association pursuant to the terms of the share purchase agreement dated May 9 executed by and amongst the bank, Sumitomo Mitsui Banking Corporation (SMBC) and State Bank of India (SBI), which would be subject to approval of the Reserve Bank of India and shareholders of the bank. The rights of SMBC and SBI that are proposed to be incorporated into the Articles of Association of the bank are subject to the fall-away thresholds of 10% and 5%, respectively. Global investment firm Carlyle group on Tuesday sold a 2.6% stake in Yes Bank for ₹ 1,775 crore through open market transactions. US-based Carlyle, through its affiliate CA Basque Investments, sold a total of 82 crore Yes Bank shares, representing a 2.62% stake in the bank on the NSE and BSE, as per the bulk deal data on the bourses. The shares were offloaded in the price range of ₹ 21.61-21.68 apiece, taking the combined transaction value to ₹ 1,774.89 crore. After the share sale, Carlyle's arm CA Basque Investments' shareholding in Yes Bank declined to 4.22% from 6.84%. Yes Bank share price has gained 18% in one month and 29% in three months. The banking stock is up 7% YTD, but has fallen 4% in the past one year. However, Yes Bank share price has gained 28% in two years and 59% in three years. At 9:20 AM, Yes Bank share price was trading 0.96% higher at ₹ 21.05 apiece on the BSE.
Mint
04-06-2025
- Business
- Mint
Yes Bank share price gains as board approves raising up to ₹16,000 crore
Yes Bank share price gained over a percent in early trade on Wednesday after the private lender's board approved raising of ₹ 16,000 crore through a mix of equity and debt to fund business growth. Yes Bank shares rose as much as 1.87% to ₹ 21.24 apiece on the BSE. The board of directors of Yes Bank approved raising of funds by way of issuance of eligible equity securities through various permissible means, of up to ₹ 7,500 crore, which would not result in an aggregate dilution of more than 10% (including dilution on account of issuance of equity securities in terms of this item and conversion of any convertible debt securities approved by the board), Yes Bank said in a regulatory filing on June 3. The board also approved raising funds by way of issuance of eligible debt securities in Indian or foreign currency up to ₹ 8,500 crore and would not result in an aggregate dilution of more than 10%, the private lender added. Yes Bank's board also approved amendments to its Articles of Association pursuant to the terms of the share purchase agreement dated May 9 executed by and amongst the bank, Sumitomo Mitsui Banking Corporation (SMBC) and State Bank of India (SBI), which would be subject to approval of the Reserve Bank of India and shareholders of the bank. The rights of SMBC and SBI that are proposed to be incorporated into the Articles of Association of the bank are subject to the fall-away thresholds of 10% and 5%, respectively. Global investment firm Carlyle group on Tuesday sold a 2.6% stake in Yes Bank for ₹ 1,775 crore through open market transactions. US-based Carlyle, through its affiliate CA Basque Investments, sold a total of 82 crore Yes Bank shares, representing a 2.62% stake in the bank on the NSE and BSE, as per the bulk deal data on the bourses. The shares were offloaded in the price range of ₹ 21.61-21.68 apiece, taking the combined transaction value to ₹ 1,774.89 crore. After the share sale, Carlyle's arm CA Basque Investments' shareholding in Yes Bank declined to 4.22% from 6.84%. Yes Bank share price has gained 18% in one month and 29% in three months. The banking stock is up 7% YTD, but has fallen 4% in the past one year. However, Yes Bank share price has gained 28% in two years and 59% in three years. At 9:20 AM, Yes Bank share price was trading 0.96% higher at ₹ 21.05 apiece on the BSE. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Time of India
04-06-2025
- Business
- Time of India
Yes Bank secures board approval to raise Rs 15,000 crore in equity and debt capital
Mumbai: Yes Bank announced late Tuesday its board has approved raising up to ₹7,500 crore in equity capital and ₹8,500 crore through debt instruments during FY26. The fundraising will be executed in multiple tranches, both in domestic and international markets. In a regulatory filing, the private sector lender stated that the equity capital will be raised through various permissible instruments, ensuring that the total dilution does not exceed 10%. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like O carro de Paolla Oliveira choca o mundo inteiro, a prova em fotos! 33 Bridges Undo The board has also cleared a resolution to raise debt capital via instruments denominated in Indian or foreign currency, totaling ₹8,500 crore. To support its strategic agreement with Japan's Sumitomo Mitsui Banking Corporation (SMBC), the bank will amend its Articles of Association. An approval to raise fresh equity will enable SMBC to infuse new capital in the bank and raise its stake. SMBC signed a definitive agreement on May 9 to acquire a 20% stake in Yes Bank for ₹13,483 crore through a secondary market transaction. As part of the agreement, SMBC will receive pro-rata pre-emptive rights to subscribe to future equity issuances by Yes Bank to maintain its stake. It will also be entitled to nominate two non-executive and non-independent directors to the board. State Bank of India (SBI), a key stakeholder, will retain the right to appoint one nominee director. Live Events Yes Bank last raised ₹15,000 crore in July 2020 through a follow-on public offer. In March 2022, the bank secured ₹8,887 crore from global private equity firms Carlyle and Advent International by issuing shares on a preferential basis. Both investors acquired a 9.99% stake in the bank. At the end of March 2025, Yes Bank had a common equity tier 1 (CET1) ratio of 13.5% while its capital adequacy ratio stood at 15.6%.
